(Clostridioides difficile) is bacteria that causes about 500,000 infections a year in the United States, according to the U.S ...

Clostridioides difficile (C. diff) is a bacterial infection that commonly affects people with ulcerative colitis (UC). It can worsen symptoms and cause complications. It can also trigger a ...

CDI = Clostridium difficile infection, UTI = Urinary tract infection, n = total sample size, N = weighted average annual population estimate, CI = confidence interval ...

Clostridium difficile infection (CDI) is considered to be the main cause of bacterial infectious diarrhea in nosocomial settings. Since the beginning of the new century a continuous rise in the ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...

Antibiotic and antifungal drug resistance pose a major public health threat. Live Science is covering the spread of this ...

Pfizer's vaccine for Clostridium difficile (C. diff ... 06425090 was undermined by a lower-than expected rate of C. diff infection (CDI) as a result of social isolation caused by the COVID ...

PF-06425090 is under clinical development by Pfizer and currently in Phase III for Clostridioides difficile Infections (Clostridium difficile Associated Disease). According to GlobalData, Phase III ...